IL147500A0 - Method for delivery of therapeutic agents using a solution of dextrin - Google Patents

Method for delivery of therapeutic agents using a solution of dextrin

Info

Publication number
IL147500A0
IL147500A0 IL14750000A IL14750000A IL147500A0 IL 147500 A0 IL147500 A0 IL 147500A0 IL 14750000 A IL14750000 A IL 14750000A IL 14750000 A IL14750000 A IL 14750000A IL 147500 A0 IL147500 A0 IL 147500A0
Authority
IL
Israel
Prior art keywords
dextrin
delivery
therapeutic agents
solution
animal
Prior art date
Application number
IL14750000A
Other languages
English (en)
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918785.8A external-priority patent/GB9918785D0/en
Priority claimed from US09/482,794 external-priority patent/US20030039960A1/en
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of IL147500A0 publication Critical patent/IL147500A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL14750000A 1999-08-10 2000-08-09 Method for delivery of therapeutic agents using a solution of dextrin IL147500A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918785.8A GB9918785D0 (en) 1999-08-10 1999-08-10 Therapeutic treatment
GBGB9924980.7A GB9924980D0 (en) 1999-08-10 1999-10-22 Therapeutic treatment
US09/482,794 US20030039960A1 (en) 2000-01-13 2000-01-13 Therapeutic treatment
PCT/GB2000/003025 WO2001012231A1 (en) 1999-08-10 2000-08-09 Method for delivery of therapeutic agents using a solution of dextrin

Publications (1)

Publication Number Publication Date
IL147500A0 true IL147500A0 (en) 2002-08-14

Family

ID=27269789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14750000A IL147500A0 (en) 1999-08-10 2000-08-09 Method for delivery of therapeutic agents using a solution of dextrin

Country Status (12)

Country Link
EP (1) EP1206284B1 (xx)
JP (1) JP2003507345A (xx)
AT (1) ATE366587T1 (xx)
AU (1) AU779579B2 (xx)
CA (1) CA2378708A1 (xx)
DE (1) DE60035504D1 (xx)
IL (1) IL147500A0 (xx)
MX (1) MXPA02001472A (xx)
NO (1) NO20020604L (xx)
NZ (1) NZ516777A (xx)
PL (1) PL353232A1 (xx)
WO (1) WO2001012231A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392666C (en) 2000-01-21 2011-12-13 Ml Laboratories Plc Dextrin containing compositions for prevention of adhesions
US20020081736A1 (en) 2000-11-03 2002-06-27 Conroy Susan E. Nucleic acid delivery
JP4426757B2 (ja) * 2000-11-03 2010-03-03 イノベータ リミテッド 核酸移送のための糖類と組み合わせたデキストリンポリマーを含む製剤
EP3120842A1 (en) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
GB8714378D0 (en) * 1987-06-19 1987-07-22 Hunchplan Ltd Parenteral delivery of drugs
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6667293B1 (en) * 1995-09-12 2003-12-23 Hybridon, Inc. Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response

Also Published As

Publication number Publication date
MXPA02001472A (es) 2002-07-02
JP2003507345A (ja) 2003-02-25
NO20020604D0 (no) 2002-02-07
NZ516777A (en) 2004-12-24
AU779579B2 (en) 2005-01-27
EP1206284A1 (en) 2002-05-22
DE60035504D1 (de) 2007-08-23
AU6456500A (en) 2001-03-13
PL353232A1 (en) 2003-11-03
CA2378708A1 (en) 2001-02-22
EP1206284B1 (en) 2007-07-11
ATE366587T1 (de) 2007-08-15
WO2001012231A1 (en) 2001-02-22
NO20020604L (no) 2002-02-07

Similar Documents

Publication Publication Date Title
IL147803A0 (en) 28-epirapalogs
PT1011781E (pt) Stent com arco
TW286273B (xx)
GB2357932B (en) Technique for enabling messaging systems to use alternative message delivery mechanisms
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
IL144728A0 (en) Iontophoresis, electroporation and combination patches for local drug delivery
LT2000095A (en) Aerosolised active agent delivery
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
HK1049438A1 (en) Sub-tenon drug delivery.
MY124214A (en) Compositions for promoting crowth
IL163573A0 (en) Conjugates of therapeutic or cytotoxic agents and biologically active peptides
HK1036970A1 (en) Compounds and compositions for delivering active agents.
IL147920A0 (en) Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants
ZA200107976B (en) Low dose estrogen interrupted hormone replacement therapy.
MXPA02005224A (es) Sistema y procedimiento mejorado para la administracion transdermica de un anticonceptivo.
ZA97976B (en) Uniform drug delivery theraphy.
HUP0105057A3 (en) Dosing and delivering system
PL336233A1 (en) Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity
MY121519A (en) Dosing regimens for lasofoxifene
IL147500A0 (en) Method for delivery of therapeutic agents using a solution of dextrin
WO2003106640A3 (en) CELL TARGETING METHODS AND COMPOSITIONS
EP1173192A4 (en) METHOD AND COMPOSITIONS FOR TARGETED MEDICINE ADMINISTRATION
GB9711389D0 (en) Bacterial pheromones and uses therefor
MXPA03006157A (es) Metodo de terapia de reemplazo de hormona y su forma de administracion.
ZA200110046B (en) Therapeutic agents.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed